T here is little information on ischemic stroke in India. [1] [2] [3] [4] The only dedicated ischemic stroke study was published in 2002, 1 focusing on etiology. Recent data from prospective registries included a mix of ischemic and hemorrhagic strokes, with little information on demographics, risk factors, etiology, and outcomes. We present data from the Indo-US Collaborative Stroke Project-a multicentre hospital-based study conducted at 5 high-volume academic tertiary hospitals across India. The Indo-US Collaborative Stroke Project was funded by the US National Institutes of Health (NIH) and the Indian Government Department of Biotechnology to study the inpatient profile of ischemic stroke in India, to train a core group of researchers to stimulate stroke infrastructure development and to lay the foundation for future scientific collaborations.
Methods
We will not make our data, analytical methods, and study materials available to other researchers.
The project was approved by each hospital's Ethics Committee. Written informed consent was obtained from consecutive adult patients with ischemic stroke admitted <2 weeks, in whom brain imaging (computed tomography/magnetic resonance imaging) confirmed infarction or perfusion-weighted imaging (computed tomographic perfusion or magnetic resonance perfusion) showed lesions in the relevant arterial territory or (for patients with transient symptoms but no radiological infarct) vascular imaging showed >70% stenosis in the relevant artery. Patients with primary intracerebral/ subarachnoid hemorrhage and those who died or were discharged from the emergency department without inpatient admission were excluded. Data were collected from January 2012 to August 2014 and entered in a secure web-based electronic platform. Data variables and definitions were consistent with the NIH Stroke Common Data Elements and American Heart and Stroke Association Background and Purpose-The Indo-US Collaborative Stroke Project was designed to characterize ischemic stroke across 5 high-volume academic tertiary hospitals in India. 5 and 90-day clinical outcomes. All investigators were trained and certified on the NIH Stroke Scale and modified Rankin Scale, trained on using the CCS web-based tool to assign stroke mechanism and interpreting neuroimaging findings. Training was conducted by US site investigators via in-person visits, conference calls, or video links. Data accuracy was confirmed with chart audits, database queries, and logic checks. Statistical analysis was performed using SPSS, version 21. P<0.05 was considered significant. 
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Results
We enrolled 2066 inpatients; 52.6% were brought in by private transportation and 1.8% by paramedics. Baseline features are presented in Table 1 . Intravenous tissue-type plasminogen activator was given to 209 patients (10.1%), intra-arterial therapy to 29 (1.4%), and 30 (1.45%) received intravenous plus intra-arterial (bridging) thrombolysis. Imaging data are shown in Table 2 . Intracranial arterial abnormalities affected ≈50% of patients (many had tandem lesions), and leukoaraiosis was frequent. In accordance, large-artery atherosclerosis was the most common mechanism (Figure [A] ). In-hospital mortality occurred in 163 patients (7.9%). Of the 2009 patients (97.2%) with 90-day follow-up, 991 (48%) had excellent 3-month outcome (modified Rankin Scale, 0-2), and 10.7% died. Figure (B multivariate logistic regression analysis age, NIH Stroke Scale score, diabetes mellitus, and small-artery occlusion subtypes were independent predictors of 90-day outcome.
Discussion
We provide comprehensive information on demographics, risk factors, mechanisms, imaging characteristics, and outcomes of inpatient ischemic stroke in India. Our results emphasize an urgent need to address modifiable vascular risk factors in India and other lower middle-income countries. The mean age (58 years) and the percentage of women (33%) was significantly lower than that of Western and Chinese populations.
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The below-60-year age group, predominantly men, are the key income generators suggesting a heavier financial burden from stroke in India. The lower percentage of women may also reflect cultural bias, with men more likely to seek medical care. We recruited from recognized stroke centers admitting more severe strokes or thrombolyzed patients, hence our thrombolysis rates are high.
Our study provides insights about stroke risk factors in India. We observed a high rate of tobacco and alcohol use, particularly in men, and a higher rate of hypertension and diabetes mellitus as compared with Western populations. 2 Among tobacco users, 53% smoked cigarettes and the rest consumed other forms prevalent in India (bidis, smokeless tobacco, and hookah), which probably confer a higher risk. Drug abuse was relatively infrequent. A novel aspect is that we used a contemporary, validated, and reliable tool (CCS) to determine mechanisms. Like results from the Hyderabad study 1 and many Eastern studies, 8 large-artery atherosclerosis was the most common subtype. Rheumatic heart disease was relatively common even among our adult population. Only 4% had known atrial fibrillation, likely reflecting under diagnosis or the lower mean age.
As opposed to prior studies, we only included imagingconfirmed stroke, and ours is the first Indian study providing detailed arterial information. Vascular imaging was obtained in 81% and typically completed on admission to facilitate intra-arterial thrombolysis decisions. Approximately half showed >50% stenosis of intracranial arteries, confirming a high rate of intracranial atherosclerosis. 9 Novel findings include the moderate extent of white-matter disease and that 100 of 1392 patients undergoing magnetic resonance imaging (7.1%) showed cerebral microbleeds, despite their relatively young age. Again, these data suggest a large burden of untreated risk factors, such as hypertension. The high rate of postischemic hemorrhage (10.9%) reflects a selection bias because only a subset of patients with clinical worsening and those receiving thrombolysis receive follow-up imaging, which is usually magnetic resonance imaging (more sensitive to detect hemorrhage). Stroke severity was high, a significant proportion had large infarcts, and ≈1:7 received intravenous or intra-arterial thrombolysis. These results may be explained by admission bias, that is, the limited availability of hospital beds and lack of health insurance leads to severe/unstable strokes or thrombolyzed patients getting admitted. We did observe lower mortality, presumably because of differences in study population (stroke care units versus rural or urban settings) although advances in care, such as thrombolysis and the prevention of early poststroke complications, may also have contributed.
Study strengths include the inclusion of consecutive imaging-confirmed stroke, detailed brain/vascular imaging analysis, use of CCS to determine etiology, intense training of coordinators/coinvestigators on data definitions with regular audits, and the availability of 90-day data in 97.2%. The geographically diverse and relatively large sample size lends generalizability to other urban settings in low/middle-income countries. However, we acknowledge that our results are not applicable to rural or private (self-pay) hospital populations. Nevertheless, the known differences between rural and urban settings may require different sets of guidelines to be developed. Our data may prove useful in advancing stroke care and designing national stroke guidelines.
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